ArticlePDF Available

Silica-nanoparticles in slow release supplement: preparation and characterization

Authors:

Abstract and Figures

The nanosilica was prepared from bamboo leaves ash by calcination method in 800°C for an hour. The result was 350 g silica from 500 g of its ash. The SEM shows a homogeneous surface of SiO2 and the EDX consists of 56,73% Si. The FTIR test indicates the Si-O-Si functional groups. The XRD shows 2θ = 21,6 which corresponds to JCPDS No. 39-1425 and 18-1170. The supplement was vitamin C tablet which prepared into slow release supplement model, by mixing of three component : generic ascorbic acid, magnesium stearate, and nanosilica in certain composition. Some assessments were carried out to determine the tablet's characteristic: the size, homogeneity, and hardness. Physical testing of the slow-release vitamin C tablet was found to meet the requirements of tablet by Indonesian Farmakope. In vitro assessment was represented by dissolution test in simulation solutions of stomach by 0,1M HCl and the intestine by citric acid. The result showed that the dissolution of the samples were slower than the control tablets. This indicates that the addition of silica-nanoparticles affect the characteristics of slow release supplement.
Content may be subject to copyright.
Journal of Physics: Conference Series
PAPER • OPEN ACCESS
Silica-nanoparticles in slow release supplement: preparation and
characterization
To cite this article: K S Budiasih et al 2019 J. Phys.: Conf. Ser. 1156 012008
View the article online for updates and enhancements.
This content was downloaded from IP address 38.145.112.114 on 06/02/2019 at 15:20
Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution
of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
Published under licence by IOP Publishing Ltd
International Conference of Chemistry (ICCHEM) 2018
IOP Conf. Series: Journal of Physics: Conf. Series 1156 (2019) 012008 IOP Publishing
doi:10.1088/1742-6596/1156/1/012008
1
Silica-nanoparticles in slow release supplement: preparation
and characterization
K S Budiasih 1*, Z Ikawati 2, Z Marsha1 A Aris1 and R Chrismara1
1 Department of Chemistry Education, Faculty of Mathematics and Natural Sciences,
Universitas Negeri Yogyakarta, Yogyakarta 55281
2 Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281
*E-mail: kunsb@uny.ac.id
Abstract. The nanosilica was prepared from bamboo leaves ash by calcination method in
800oC for an hour. The result was 350 g silica from 500 g of its ash. The SEM shows a
homogeneous surface of SiO2 and the EDX consists of 56,73% Si. The FTIR test indicates the
Si-O-Si functional groups. The XRD shows = 21,6 which corresponds to JCPDS No. 39-
1425 and 18-1170. The supplement was vitamin C tablet which prepared into slow release
supplement model, by mixing of three component : generic ascorbic acid, magnesium stearate,
and nanosilica in certain composition. Some assessments were carried out to determine the
tablet’s characteristic: the size, homogeneity, and hardness. Physical testing of the slow-release
vitamin C tablet was found to meet the requirements of tablet by Indonesian Farmakope. In
vitro assessment was represented by dissolution test in simulation solutions of stomach by
0,1M HCl and the intestine by citric acid. The result showed that the dissolution of the samples
were slower than the control tablets. This indicates that the addition of silica-
nanoparticlesaffect the characteristics of slow release supplement.
1. Introduction
Silica was found in several biomass, including the side product of agriculture. The silica in the form of
nanoparticles form biomass were developed in recent years, ie from rice husk ash [1] and coconut shell
[2]. Application of biomass based silica-nanoparticles were reported in the preparation of several
industrial product, i.e. in food industry [3] and drug delivery [4]. The size of nanoparticles give an
advantage in mobilization as nanocarrier. It was conducted in the delivery of curcumin [5]. Kumar et
al, (2016) developed the silica-nanoparticles from bamboo leaf. Bamboo leaves contain more than
70% of silica [6]. This research on the preparation of oral supplement was supported by silica-
nanoparticles (SNs). This paper reported the result of preliminary experiment with vitamin C as the
supplement. The utilization of SNs is the part of the medical application of silica-nanoparticles as drug
carrier. Slow release supplement is a model of SNs supported drug.
Vitamin C, in this case, was selected as the sample of slow release supplement. People use vitamin
C as the supplement which is usually needed in increasing the body resistance. The development of
slow release drug / supplement is needed to decrease the frequency of the drug/supplement
consumption. The addition of supporting material as drug carrier will accommodate this purpose. One
of the recent research of drug carrier in nano medicine is silica-nanoparticles (SNs) [7]. In vivo study
is needed to find the bioavailability and biocompatibility in the human body, which is begin
with the application in animal model [8-9].
International Conference of Chemistry (ICCHEM) 2018
IOP Conf. Series: Journal of Physics: Conf. Series 1156 (2019) 012008 IOP Publishing
doi:10.1088/1742-6596/1156/1/012008
2
2. Material and Method
2.1. Materials
The bamboo leaves were collected from Sleman Yogyakarta, Indonesia. The main chemicals (HCl,
Sodium citrate, Magnesium Stearate, and buffer) were from Merck, vitamin C from IPI, aquadest from
The Chemistry Laboratory, UNY.
2.2. Preparation of silica from bamboo ash
The bamboo ash was prepared by direct drying the leaves under the sun, followed by combustion in
traditional stove, and calcined by muffle furnace at 800 0C in 6 hours. The product was then washed
in 0,1 M HCl (by ratio 1:6) and well stirred in 60 minutes, and filtered by Whatman filter paper after
24 hours and then washed in water until neutral. The residue was then heated in the oven at 110 °C in
2 hours to remove the retained water [6].
2.3. Characterization of nanosilica
The morphology of the silica was determined by Scanning Electron Microscopy-Electron Dispersive
X-Ray Analyser (SEM -EDX) of JEOL JED-2300 model, and then continued to determine the
crystalinity by X Ray diffraction (XRD Lab-X Type 6000 Shimadzu Japan). The infrared spectrum
was recorded by Fourier Transform InfraRed (FTIR) Horizon MB3000.
2.4. Preparation of BNs-supported supplement
Preparation of SNs supported supplement was conducted by mixing the materials: vitamin C,
magnesium stearate and SNs in certain composition and pressed to round shaped tablets. The control
sample was the mixture without SNs. The characteristic of tablets include the homogeneity, size, and
hardness of the tablets. The main characteristic is the dissolution process which was determined by
dissolution test in variation of media vs. time of dissolution. Dissolutions test was conducted in both
HCl and sodium stearate media, as the simulation media of stomach and intestine.
3. Result and Discussion
3.1 Preparation of nanosilica from bamboo leaves
The yield from 700 grams bamboo leaves was 502 grams charcoal which was then calcined at 800oC
in 6 hours to get 350 grams of greyish ash of silica.
A
B
Figure 1. The SEM image of silica [(A= 5000x, B = 10.000x ]
3.2 The Sem-EDX result of the nanosilica
The morphology of the silica was characterized by Scanning Electron Microscope -Electron
Dispersive X-Ray analyser). The SEM image of the silica from bambo leaves was shown in figure1.
Figure 1 shows the soft and homogenous surface of silica. The particles have ellipsoid and sphere
shape. Stanley et al., (2014) also reported the plate and sphereshape with the size of the aggregate
wasin range of 0.5-1.0 µm [10].
0,5µmE
0,8µm
International Conference of Chemistry (ICCHEM) 2018
IOP Conf. Series: Journal of Physics: Conf. Series 1156 (2019) 012008 IOP Publishing
doi:10.1088/1742-6596/1156/1/012008
3
The EDX result is shown in figure 2 indicating that the composition of the ash are 56.73% Si and
43.26% oxygen. The pure SiO2 contained 58.63% Si, so this result was comparable to the
previous publication [11]].
Figure. 2. The EDX result of bamboo leaf ash.
3.3. The FTIR Spectra of the nanosilica
The infrared spectrum of bamboo leaf silica after calcined at 600oC was shown in figure 3
and the vibration characteristic was listed in table 1. This spectrum showed the vibration of
OH, C-H, Si-O-Si, and Si-OH, which are associated with silica
Figure 3. The Infrared spectrum of bamboo leaf silica.
Table 1. The characteristic vibrations of the silica.
Vibration
References
3749.62 Stretching Vibration of OH
form Si-OH
Stanley and Nesaraj, 2014
[12]
Priyanto, 2015 [13]
Stretching Vibration of C-H
Wang et al, 2000 [14]
1095.67
Asymmetric stretching of Si-O
of Si-O-Si
Stanley and Nesaraj, 2014
[12];
786.96
Stretching Vibration of Si-O in
Si-OH
Priyanto, 2015 [13]
Figure 3
.
International Conference of Chemistry (ICCHEM) 2018
IOP Conf. Series: Journal of Physics: Conf. Series 1156 (2019) 012008 IOP Publishing
doi:10.1088/1742-6596/1156/1/012008
4
3.4 The X Ray Diffaction analysis of the nanosilica
The X- Ray diffraction analysis on the silica shows the pattern on the range of 2θ of 2º to 80º . The
XRD pattern shows a sharp peak on 2θ=21.6º associated to Si. According to PDF No. 39-1425 and 18-
1170 from JCPDS (figure 4b), Si has characteristic peaks on 2θ=20.5 º, 21.6 º, and 23.3º. The
formation of crystalline silica started on 650o C and completed in 800o C. The XRD pattern of the
sample was shown in Figure 4 (a) and compared with the pattern in JPPDS (b).
Figure 4. (a) The XRD pattern of bamboo leaf silica (b)The JCPDS data (reference).
The particle size was 7.057 nm, following Scherrer formula. It matches with the requirements of
nanoparticles size, in range 5-100 nm. This product was labeledas Bamboo Nanosilica BNs). This
product was then applied in the preparation of BNs suppported supplement.
3.5 Preparation and it’s in vitro study of slow release supplement.
Preparation of BNs supported supplement was conducted by mixing the composition as shown in
table 2. The mixture was then pressed to round shaped tablets with diameter of 0.72 cm. The
weight of each tablet was about 160 mg. The control sample was the mixture without BNs.
Table 2. Formulation of BNs supported Vitamin C.
No
Sample code
composition
Vit.C
Magnesium stearate
BNs
1
A
140 mg
20 mg
-
2
B
100 mg
50mg
10 mg
3
C
100 mg
45 mg
15 mg
4
D
100 mg
40 mg
20 mg
The physical characteristic of tablets is determined in terms of size, weight, hardness, fragility and
dissolved time. The result was listed in table 3.
Table 3.The physical characteristic of BNs - Vitamin C.
Physical characteristic
Formula
A
B
C
D
Mass (mg)
170.07
170.10
170.17
170.28
Diameter (cm)
0.71
0.72
0.72
0.72
Hardness (kg/cm2)
0.396
0.674
0.676
1.188
Fragility (%)
0.2
0.7
0.8
1.4
Dissolved time (minute)
8.5
5
6
6
All the result have fulfiled the requirement of oral supplement according to the 4th Indonesian
Farmakope, that the standard deviation of the value is not more than 10%. The BNs addition was also
found to increase the hardness of the tablets. The higher the hardness, was found the slower the
supplement released. According The 4th Indonesian Farmakope, the maximum hardness of the
a
b
3.4
International Conference of Chemistry (ICCHEM) 2018
IOP Conf. Series: Journal of Physics: Conf. Series 1156 (2019) 012008 IOP Publishing
doi:10.1088/1742-6596/1156/1/012008
5
supplement tablets is 1.5 kg/cm.2. It means, all the samplesmeet the requirement of the hardness. The
fragility of BNs -vitamin C also meet the requirement of the standard supplement tablet, namely
maximum 1%. All samples ranged in 0.4 0.8 %, so that the parameter of the formulation of a good
tablet also has been fulfilled. The standard of dissolved time of this supplement tablet is 15 minutes
(max). All samples also meet the requirements of Indonesian Farmakope [14]
The main characteristic is the dissolution process which is determined by dissolution test by
variation of media vs time of dissolution. This test was associated with the ability of the drug in the
interaction with the human body [15]. dissolution test was conducted in both HCl and sodium stearate
media, as the simulation media of stomach and intestine. The result of the dissolution test of the
sample was shown in figure 5.
Interpretation of the dissolution data was carried out by observation of the curve pattern of the
formula in two media. The HCl medium is the simulation of stomach and the sodium citrate is the
simulation medium of intestine. The profile of dissolution was formed by plotting of the amount of the
released particles of the supplement vs time (in minute) (figure 5). The observation was carried out in
the sample of 10% weight of the tablets. The rate of the release of the supplement was proportional to
the BNs contained in the tablets. The higher the silica content, results in the slower the release. The
standard of dissolution time of slow release drug by Indonesian National Agency of Drug and Food
Control is 60 minutes. It was provided that the addition of silica-nanoparticles was useful in
preparation of slow release supplement.
4. Conclusion
The preparation of bamboo leaf silica-nanoparticles (BNs) was successfully conducted by calcination
of bamboo leaves ash at 800 oC in 6 hours. The particles were crystalline and the size is 7.057 in
average. The utilization of bamboo leaf silica-nanoparticles in supplement preparation meet to the
requirement of the slow releass drug / supplement, referring to Indonesian National Agency of Drug
and Food Control.
References
[1] Pukird, S, Chamninok P, Samran ,S, Kasian, P, Noipa, K, and Chow, L 2009 JMMM
19 33-37
[2] Madakson, PB, Yawas DY, and Apasi, A 2012 Int. J. Eng. Sci. Tech (IJEST) 4 03 1190-
1198
[3] Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, Aitken R and Watkins 2008,
Food Additives. Contaminants, 25 3 241258
[4] De Jong, W H and Borm P J A 2008, Int. J. Nanomed. 3(2) 133-149.
[5] Bolouki A, Rashidi L, Vasheghani-Farahani L and Piravi-Vanak Z 2015 Int. J. Nanosci.
Nanotechnol. 11 3, 139-146.
[6] Kumar, V, Tiwari P, Krishnia L, Kumari R, Sing, A, Ghosh A and Tyagi P K 2016 Adv.Mater.
Lett. 74 271-276
[7] Tang L and Cheng J 2013 Nano Today 8 290-312
[8] Asefa T and Tao Z 2012 Chem. Res. Toxicol. 25 2265−84.
4 6 8 10121416182022
0
1
2
3
4
5
6
7
8
obat yang terdesolusi (%)
Waktu (menit)
A
B
C
D
HCl medium
4 6 8 10121416182022
2
3
4
5
6
7
8
obat yang terdesolusi(%)
waktu (menit)
A
B
C
D
Sodium citrate medium
Figure 5. The dissolution test in 2 simulation media
International Conference of Chemistry (ICCHEM) 2018
IOP Conf. Series: Journal of Physics: Conf. Series 1156 (2019) 012008 IOP Publishing
doi:10.1088/1742-6596/1156/1/012008
6
[9] K S Budiasih, C Anwar, S J Santosa, H Ismail and I P Sari 2013 J. Chem. Pharm. Res. 5(9) 34-
39
[10] Tang L and Cheng J 2013 Nano Today 8 290-312
[11] A K Prodjosantosa, K S Budiasih, Utomo P, Indah D and Prasiwi H 2018 Orient. J. Chem.
34
[12] Stanley R and Nesaraj A S 2014 Int. J. App. Sci. Eng. 12(1) 9-21
[13] Priyanto A, Ilmu F, Dan T, Islam U and Walisongo N 2015. Skripsi. Semarang:
Universitas Islam Negeri Walisongo.
[14] Ditjen Pengawas Obat dan Makanan 1995 Farmakope Indonesia. Edisi IV (Jakarta:
Departemen Kesehatan RI)
[15] Vijayalakshmi U, Balamurugan A and Rajeswari S 2005 J. Trends. Biomater. Artif Organs
18(2) 101-105
Ackowledgment
Thank to The Ministry of Research, Technology and Higher Education for the Research Funding.
... Silica (SiO 2 ) has been the focus of extensive study because of the advantages it provides for a wide variety of applications. Silica can be present in nature as a major component of sand or in species such as rice husk, coffee husk, wheat husk, sugar cane bagasse, corn cob ash, and fly ash [7].Silica is widely available in the world, accounting for 59 percent of the Earth's crust [8]. ...
Article
Full-text available
The present study revealed a low-cost process for utilizing desert sand for preparing nanosilica by sol-gel technique. This work required sodium hydroxide, concentrated hydrochloric acid, distillate water as raw materials, and Iraqi sand. Nanosilica sample was characterized by X-Ray Diffraction (XRD), scanning electron microscopy analysis (SEM), atomic force microscope(AFM), surface area (BET) method, and fourier transform infrared (FTIR). The XRD result of produced sample is referred to as amorphous silica, and it has a broad peak at 2Θ= 22° – 22.5 º. SEM showed spherical, agglomerated silica particles with a diameter range of 26.57–28.93 nm. In addition, the average particle size was 76.35nm, with a dimension range of 40-110 nm, and the surface area was 510.96 m²/g. The inclusion of hydrogen-bonded silanol groups (Si–O–H) at 3437.15 cm-¹ and siloxane groups (Si–O–Si) at 1087.85 cm-¹in the FTIR spectra.
Article
Full-text available
The use of nanotechnology in medicine and more specifically drug delivery is set to spread rapidly. Currently many substances are under investigation for drug delivery and more specifically for cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient. The kind of hazards that are introduced by using nanoparticles for drug delivery are beyond that posed by conventional hazards imposed by chemicals in classical delivery matrices. For nanoparticles the knowledge on particle toxicity as obtained in inhalation toxicity shows the way how to investigate the potential hazards of nanoparticles. The toxicology of particulate matter differs from toxicology of substances as the composing chemical(s) may or may not be soluble in biological matrices, thus influencing greatly the potential exposure of various internal organs. This may vary from a rather high local exposure in the lungs and a low or neglectable exposure for other organ systems after inhalation. However, absorbed species may also influence the potential toxicity of the inhaled particles. For nanoparticles the situation is different as their size opens the potential for crossing the various biological barriers within the body. From a positive viewpoint, especially the potential to cross the blood brain barrier may open new ways for drug delivery into the brain. In addition, the nanosize also allows for access into the cell and various cellular compartments including the nucleus. A multitude of substances are currently under investigation for the preparation of nanoparticles for drug delivery, varying from biological substances like albumin, gelatine and phospholipids for liposomes, and more substances of a chemical nature like various polymers and solid metal containing nanoparticles. It is obvious that the potential interaction with tissues and cells, and the potential toxicity, greatly depends on the actual composition of the nanoparticle formulation. This paper provides an overview on some of the currently used systems for drug delivery. Besides the potential beneficial use also attention is drawn to the questions how we should proceed with the safety evaluation of the nanoparticle formulations for drug delivery. For such testing the lessons learned from particle toxicity as applied in inhalation toxicology may be of use. Although for pharmaceutical use the current requirements seem to be adequate to detect most of the adverse effects of nanoparticle formulations, it can not be expected that all aspects of nanoparticle toxicology will be detected. So, probably additional more specific testing would be needed.
Article
Full-text available
A review of current and projected nanotechnology-derived food ingredients, food additives and food contact materials is presented in relation to potential implications for consumer safety and regulatory controls. Nanotechnology applications are expected to bring a range of benefits to the food sector, including new tastes, textures and sensations, less use of fat, enhanced absorption of nutrients, improved packaging, traceability and security of food products. The review has shown that nanotechnology-derived food and health food products are set to grow worldwide and, moreover, a variety of food ingredients, additives, carriers for nutrients/supplements and food contact materials is already available in some countries. The current level of applications in the European food sector is at an elementary stage; however, it is widely expected that more and more products will be available in the EU over the coming years. The toxicological nature of hazard, likelihood of exposure and risk to consumers from nanotechnology-derived food/food packaging are largely unknown and this review highlights major gaps in knowledge that require further research. A number of uncertainties and gaps in relevant regulatory frameworks have also been identified and ways of addressing them proposed.
Article
Silica, generally known as silicon dioxide is insulating in nature whereas silicon is semiconducting. These two materials are widely used in sensing and electronic devices. In order to full-fill demand of silicon, sources other than sand, have to explore for silicon extraction. In this report, bamboo culms have been subjected to thermo chemical decomposition at high temperature (1250 °C) in an inert atmosphere. After pyrolysis, contents in residual of bamboo culms have been characterized by using scanning electron microscope (SEM), transmission electron microscope (TEM) and X-ray diffraction (XRD). Nanosized, pure crystalline Si has been formed. Si as well as charcoal is found to be crystalline in nature. No silicon carbide formation observed.
Article
Nanomedicine, the use of nanotechnology for biomedical applications, has potential to change the landscape of the diagnosis and therapy of many diseases. In the past several decades, the advancement in nanotechnology and material science has resulted in a large number of organic and inorganic nanomedicine platforms. Silica nanoparticles (NPs), which exhibit many unique properties, offer a promising drug delivery platform to realize the potential of nanomedicine. Mesoporous silica NPs have been extensively reviewed previously. Here we review the current state of the development and application of nonporous silica NPs for drug delivery and molecular imaging.
Article
In this review, recent reports on the biocompatibility of mesoporous silica nanoparticles (MSNs) are reviewed, with special emphasis being paid to the correlations between MSNs' structural and compositional features and their biological effects on various cells and tissues. First, the different synthetic routes used to produce the most common types of MSNs and the various methods employed to functionalize their surfaces are discussed. This is, however, done only briefly because of the focus of the review being the biocompatibility of the materials. Similarly, the biological applications of MSNs in areas such as drug and gene delivery, biocatalysis, bioimaging, and biosensing are briefly introduced. Many examples have also been mentioned about the biological applications of MSNs while discussing the materials' biocompatibility. The cytotoxicity of different types of MSNs and the effects of their various structural characteristics on their biological activities, which are the focus of this review, are then described in detail. In addition, synthetic strategies developed to reduce or eliminate any possible negative biological effects associated with MSNs or to improve their biocompatibility, as necessary, are illustrated. At the same time, recent reports on the interactions between MSNs and various in vivo or in vitro biological systems, plus our opinions and remarks on what the future may hold for this field, are included.
  • P B Madakson
  • D Y Yawas
Madakson, PB, Yawas DY, and Apasi, A 2012 Int. J. Eng. Sci. Tech (IJEST) 4 03 1190-1198
  • Q Chaudhry
  • M Scotter
  • J Blackburn
  • B Ross
  • A Boxall
  • L Castle
  • Aitken R Watkins
Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, Aitken R and Watkins 2008, Food Additives. Contaminants, 25 3 241-258
  • De Jong
  • W Borm
De Jong, W H and Borm P J A 2008, Int. J. Nanomed. 3(2) 133-149.
  • A Bolouki
  • L Rashidi
  • L Vasheghani-Farahani
Bolouki A, Rashidi L, Vasheghani-Farahani L and Piravi-Vanak Z 2015 Int. J. Nanosci. Nanotechnol. 11 3, 139-146.
  • V Kumar
  • P Tiwari
  • L Krishnia
  • R Kumari
  • A Sing
  • Ghosh A Tyagi
Kumar, V, Tiwari P, Krishnia L, Kumari R, Sing, A, Ghosh A and Tyagi P K 2016 Adv.Mater. Lett. 74 271-276